CoChat

The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder

Stein, Dan, Stein, Murray, Goodwin, Wendy, Kumar, Rajinder, Hunter, Brian · 2001 · Psychopharmacology

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Rationale The DSM-IV includes the specifier "generalized" to refer to social anxiety disorder (social phobia) patients if the fears include "most social situations". The focus on interventions such as the selective serotonin reuptake inhibitors (SSRIs) for generalized social anxiety disorder arguably runs the risk that inadequate treatment will be provided to patients with the non-generalized or discrete subtypes. There are, however, few data to address whether more generalized and less generalized subgroups of social anxiety disorder differ in response to medication.Objective To compare response of more generalized and less generalized social anxiety disorder to pharmacotherapy.Methods Data from three randomized placebo-controlled double-blind multicenter trials of the SSRI paroxetine in social anxiety disorder were pooled. Response on the Clinical Global Impression Global Improvement item was analyzed using logistic regression, and change in total Liebowitz Social Anxiety Score was analyzed using analysis of variance, with both models incorporating treatment (paroxetine vs placebo), subgroup (more generalized vs less generalized), demographic, and clinical variables.Results The prevalence of more generalized social anxiety disorder was higher in females than in males. However, there was no significant difference in terms of age or clinical characteristics (duration of condition, baseline pulse, mean arterial blood pressure). At treatment endpoint there were significant treatment effects (for paroxetine vs placebo), but no significant subgroup effects (for more generalized vs less generalized).Conclusions Although the current database is limited insofar as few patients with discrete social anxiety disorder would have been included, it is helpful in addressing the value of medication for patients lying on the spectrum from generalized to non-generalized and discrete social anxiety disorder. Paroxetine was effective in both more generalized and in less generalized social anxiety disorder.

Overview

Integrity signals

Registry

Crossref · 10.1007/s002130100880

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Cited by

See all 43

Metadata

Authors
Stein, D., Stein, M., Goodwin, W., Kumar, R., & Hunter, B.
Affiliations
  • Stellenbosch University (ZA)
  • University of California San Diego (US)
  • GlaxoSmithKline (United Kingdom) (GB)
Venue
Psychopharmacology
Published
2001-11-01
Volume
158
Issue
3
Pages
267-272
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2065666574
Cited by
39
References
31
Citations by year
2022: 1 · 2021: 1 · 2018: 1 · 2016: 2 · 2013: 1
FWCI
9.46
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Funders
Medical Research Council
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
Keywords
paroxetine, social anxiety disorder, generalized social anxiety, selective serotonin reuptake inhibitors, pharmacotherapy response, Liebowitz Social Anxiety Scale, Clinical Global Impression Scale
MeSH terms
Adult, Analysis of Variance, Anxiety Disorders, Double-Blind Method, Female, Humans, Male, Middle Aged, Confidence Intervals, Logistic Models, Odds Ratio, Selective Serotonin Reuptake Inhibitors, Paroxetine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.